scholarly journals Novel spectroscopic biomarkers are applicable in non-invasive early detection and staging classification of colorectal cancer

Neoplasma ◽  
2020 ◽  
Author(s):  
M. MISKOVICOVA ◽  
V. FRYBA ◽  
L. PETRUZELKA ◽  
V. SETNICKA ◽  
A. SYNYTSYA ◽  
...  
Diagnostics ◽  
2020 ◽  
Vol 10 (12) ◽  
pp. 1077
Author(s):  
Maider Beitia ◽  
Paolo Romano ◽  
Gorka Larrinaga ◽  
Jon Danel Solano-Iturri ◽  
Annalisa Salis ◽  
...  

Colorectal cancer (CRC) is the second cause of death in men and the third in women. This work deals with the study of the low molecular weight protein fraction of sera from patients who underwent surgery for CRC and who were followed for several years thereafter. MALDI-TOF MS was used to identify serum peptidome profiles of healthy controls, non-metastatic CRC patients and metastatic CRC patients. A multiple regression model was applied to signals preliminarily selected by SAM analysis to take into account the age and gender differences between the groups. We found that, while a signal m/z 2021.08, corresponding to the C3f fragment of the complement system, appears significantly increased only in serum from metastatic CRC patients, a m/z 1561.72 signal, identified as a prothrombin fragment, has a significantly increased abundance in serum from non-metastatic patients as well. The findings were also validated by a bootstrap resampling procedure. The present results provide the basis for further studies on large cohorts of patients in order to confirm C3f and prothrombin as potential serum biomarkers. Thus, new and non-invasive tests might be developed to improve the classification of colorectal cancer.


2021 ◽  
Author(s):  
Maria Gallardo-Gomez ◽  
Mar Rodriguez-Girondo ◽  
Nuria Planell ◽  
Sebastian Moran ◽  
Luis Bujanda ◽  
...  

Early detection has proven to be the most effective strategy to reduce the incidence and mortality of colorectal cancer (CRC). Nevertheless, most current screening programs suffer from low participation rates. A blood test may improve both the adherence to screening and the selection to colonoscopy. In this study, we conducted a serum-based discovery and validation of cfDNA methylation biomarkers for CRC screening in a multicentre cohort of 453 serum samples including healthy controls, benign pathologies, advanced adenomas (AA), and CRC. First, we performed an epigenome-wide methylation analysis with the MethylationEPIC array using a sample pooling approach, followed by a robust prioritization of candidate biomarkers for the detection of advanced neoplasia (AN: AA and CRC). Then, candidate biomarkers were validated by pyrosequencing in independent individual cfDNA samples. We report GALNT9, UPF3A, WARS, and LDB2 as new non-invasive biomarkers for the early detection of AN. The combination of GALNT9/UPF3A by logistic regression discriminated AN with 78.8% sensitivity and 100% specificity, outperforming the commonly used fecal immunochemical test and the methylated SEPT9 blood test. Overall, our results suggest that the combination methylated GALNT9/UPF3A has the potential to serve as a highly specific and sensitive blood-based test for screening and early detection of CRC.


Author(s):  
Syed Ahsin Ali Shah ◽  
Nazneen Habib ◽  
Wajid Aziz ◽  
Ehsan Ullah Khan ◽  
Malik Sajjad Ahmed Nadeem

Background: The medical researchers are developing different non-invasive methods for early detection of Neurodegenerative Diseases (NDDs) when pharmacological interventions are still possible to further prevent the disease progression. The NDDs are associated with the degradation in the complex gait dynamics and motor activity. The classification of gait data using machine learning techniques can assist the physicians for early diagnosis of the neural disorder when clinical manifestation of the diseases is not yet apparent. Aims: The present study was undertaken to classify the control and NDD subjects using decision trees based classifiers (Random Forest (RF), J48 and REPTree). Methodology: The data used in the study comprises of 16 control, 20 Huntington’s Disease (HD), 15 Parkinson’s Disease (PD), and 13 Amyotrophic Lateral Sclerosis (ALS) subjects, which were taken from publicly available database from Physionet. The age range of control subjects was 20-74, HD subjects was 36-70, PD subjects was 44-80, and ALS subjects was 29-71. There were 13 attributes associated with the data. Important features/attributes of the data were selected using correlation feature selection - subset evaluation (cfs) method. Three tree based machine learning algorithms (RF, J48 and REPTree) were used to classify the control and NDD subjects. The performance of classifiers were evaluated using Precision, Recall, F-Measure, MAE and RMSE. Results: In order to evaluate the performance of tree based classifiers, two different settings of data i.e. complete features and selected features were used. In classifying control vs HD subjects, RF provides the robust separation with classification accuracy of 84.79% using complete features and 83.94% using selected features. While in classifying control vs PD subjects, and control vs ALS subjects, RF also provides the best separation with classification accuracy of 86.51% and 94.95% respectively using complete features and 85.19% and 93.64% respectively using selected features. Conclusion: The variability analysis of physiological signals provides a valuable non-invasive tool for quantifying the system of dynamics of healthy subjects and to examine the alternations in the controlling mechanism of these systems with aging and disease. It is concluded that selected features encode adequate information about neural control of the gait. Moreover, the selected features along with tree based machine learning algorithms can play a vital for early detection of NDDs, when pharmacological interventions are still possible.


2012 ◽  
Vol 23 ◽  
pp. iv23
Author(s):  
Deeqa Ahmed ◽  
Trude Ågesen ◽  
Stine Danielsen ◽  
Michael Bretthauer ◽  
Espen Thiis-Evensen ◽  
...  

2010 ◽  
Vol 48 (08) ◽  
Author(s):  
A Rosenthal ◽  
H Köppen ◽  
R Musikowski ◽  
R Schwanitz ◽  
J Behrendt ◽  
...  

2007 ◽  
Vol 45 (05) ◽  
Author(s):  
F Sipos ◽  
S Spisák ◽  
T Krenács ◽  
O Galamb ◽  
B Galamb ◽  
...  

2019 ◽  
Vol 31 (1) ◽  
Author(s):  
Antonio Francavilla ◽  
Sonia Tarallo ◽  
Barbara Pardini ◽  
Alessio Naccarati

2020 ◽  
Vol 22 (1) ◽  
pp. 137-145
Author(s):  
Tomasz Mackiewicz ◽  
Aleksander Sowa ◽  
Jakub Fichna

: Colitis-associated colorectal cancer (CAC) remains a critical complication of ulcerative colitis (UC) with mortality of approximately 15%, which makes early CAC diagnosis crucial. The current standard of surveillance, with repetitive colonoscopies and histological testing of biopsied mucosa samples is burdensome and expensive, and therefore less invasive methods and reliable biomarkers are needed. Significant progress has been made thanks to continuous extensive research in this field, however no clinically relevant biomarker has been established so far. This review of the current literature presents the genetic and molecular differences between CAC and sporadic colorectal cancer and covers progress made in the early detection of CAC carcinogenesis. It focuses on biomarkers under development, which can be easily tested in samples of body fluids or breath and, once made clinically available, will help to differentiate between progressors (UC patients who will develop dysplasia) from non-progressors and enable early intervention to decrease the risk of cancer development.


Sign in / Sign up

Export Citation Format

Share Document